X-Ray Radiation Exposure for Children Should Be Reduced: FDA

|

Federal health regulators are putting forward new recommendations that are designed to protect children from unnecessary radiation exposure

The FDA released new guidance this week, calling for manufacturers to demonstrate that X-ray imaging devices are safe and effective for use on children before putting those devices on the market. The agency also proposes that any manufacturers who fail to do so will have to label the device as potentially hazardous to children.

The new recommendations were announced on May 9, and the FDA is seeking public comment on the draft guidance before finalization.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The FDA has joined forces with the Alliance for Radiation Safety in Pediatric Imaging (ARSPI) and the Medical Imaging and Technology Alliance (MITA), as well as manufacturers. The FDA has also launched a pediatric X-ray imaging website that provides information on the health risks and benefits of X-ray imaging on children.

The efforts comes as a result of the FDA’s “Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging”, which was launched in February 2010 after the discovery of CT scan radiation over-exposure problems that may have affected more than 200 patients at Cedars-Sinai Medical Center in Los Angeles. In the course of the resulting investigation, the FDA found that at least 385 patients had received excessive radiation while undergoing CT brain perfusion scans at a number of hospitals in California and Alabama.

In November 2010, the FDA recommended that the radiation therapy industry make changes to equipment and training to lessen the risk of radiation overdose for patients. The recommendations came after a year-long investigation by the FDA which concluded that nearly all radiation exposure problems suffered by patients are due to operator error and are rarely contributed to by broken CT scanners.

CT scan procedures and other forms of radiation therapy across the country came under close scrutiny prior to the recommendations by the FDA after the discovery that a number of patients have suffered radiation overexposure from CT Scans performed incorrectly.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

More than 2,000 Depo-Provera brain tumor lawsuits have been filed in state and federal courts nationwide, according to recent court documents, with potentially thousands more claims pending.
A federal judge will meet with lead counsel in the Suboxone litigation tomorrow to receive an update on the number of Suboxone lawsuits filed and the status of discovery.